Professor and Vice Chair for Research
Atrium Health Wake Forest School of Medicine
Charlotte, North Carolina, United States
Disclosure(s): Abbott Laboraties (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Abbvie (Terminated, October 28, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Bausch Health Cos Inc (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CVS Health Corp (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Edwards Life Science Corp (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); GlaxoSmithKline (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Johnson & Johnson (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Novartis Pharmaceuticals (Terminated, August 12, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Novocure Limited (Terminated, December 12, 2022) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Pfizer, Inc. (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds, Research Support including clinical trials & the principal or named investigator); Sanofi (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); United Health Group (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Vertex (Terminated, August 12, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Viatris (Terminated, August 12, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Zimmer Biomet (Terminated, August 12, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Saturday, April 29, 2023
2:00 PM – 3:30 PM ET